Literature DB >> 26725954

Concerted action of histone methyltransferases G9a and PRMT-1 regulates PGC-1α-RIG-I axis in IFNγ treated glioma cells.

Ruchi Ghildiyal1, Ellora Sen2.   

Abstract

IFNγ induced de-differentiation markers are negatively regulated by retinoic acid inducible gene (RIG-I) in glioma cells. In addition to RIG-I, IFNγ treatment increased H3K9me2; histone methyltransferases (HMTs) G9a and protein arginine methyltransferase-1 (PRMT-1) levels. While G9a inhibition further increased IFNγ induced RIG-I, PRMT-1 inhibition abrogated IFNγ elevated RIG-I levels. IFNγ induced Sp1 and NFκB served as negative regulators of RIG-I, with decreased occupancy of Sp1 and NFκB observed on the RIG-I promoter. A diminished H3K9Me2 enrichment was observed at the NFκB but not at Sp-1 binding site. IFNγ induced PPAR gamma coactivator-1 alpha (PGC-1α) positively regulated RIG-I; with PRMT-1 and G9a affecting PGC-1α in a counter-regulatory manner. These findings demonstrate how concerted action of HMTs aid PGC-1α driven RIG-I for the sustenance of glioma cells in a de-differentiated state.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G9a; IFNγ; NFκB; PGC-1α; RIG-I

Mesh:

Substances:

Year:  2015        PMID: 26725954     DOI: 10.1016/j.cyto.2015.12.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

1.  Expression of the Human Serotonin 5-HT7 Receptor Rescues Phenotype Profile and Restores Dysregulated Biomarkers in a Drosophila melanogaster Glioma Model.

Authors:  Florestan Courant; Marion Maravat; Wanyin Chen; David Gosset; Lauren Blot; Nadège Hervouet-Coste; Vincent Sarou-Kanian; Séverine Morisset-Lopez; Martine Decoville
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

Review 2.  Potential Epigenetic-Based Therapeutic Targets for Glioma.

Authors:  Lanlan Zang; Shukkoor Muhammed Kondengaden; Fengyuan Che; Lijuan Wang; Xueyuan Heng
Journal:  Front Mol Neurosci       Date:  2018-11-15       Impact factor: 5.639

Review 3.  EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors.

Authors:  Barbara Kunzler Souza; Natalia Hogetop Freire; Mariane Jaeger; Caroline Brunetto de Farias; Algemir L Brunetto; André T Brunetto; Rafael Roesler
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

4.  Inhibiting Arginine Methylation as a Tool to Investigate Cross-Talk with Methylation and Acetylation Post-Translational Modifications in a Glioblastoma Cell Line.

Authors:  Sabrina Francesca Samuel; Alistair James Marsden; Srihari Deepak; Francisco Rivero; John Greenman; Pedro Beltran-Alvarez
Journal:  Proteomes       Date:  2018-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.